BG103214A - Твърди пянообразуващи препарати, съдържащи активно вещество - Google Patents
Твърди пянообразуващи препарати, съдържащи активно веществоInfo
- Publication number
- BG103214A BG103214A BG103214A BG10321499A BG103214A BG 103214 A BG103214 A BG 103214A BG 103214 A BG103214 A BG 103214A BG 10321499 A BG10321499 A BG 10321499A BG 103214 A BG103214 A BG 103214A
- Authority
- BG
- Bulgaria
- Prior art keywords
- active substance
- solid foam
- substance containing
- containing preparation
- forming active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/04—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent
- C08J9/12—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent
- C08J9/122—Hydrogen, oxygen, CO2, nitrogen or noble gases
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2339/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Derivatives of such polymers
- C08J2339/04—Homopolymers or copolymers of monomers containing heterocyclic rings having nitrogen as ring member
- C08J2339/06—Homopolymers or copolymers of N-vinyl-pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Твърдите пенообразуващи препарати съдържат активно вещество на основата на термопластично обработени полимери. Последните се получават чрез екструдиране на стопилка от един или повече полимери, коятосъдържа активно вещество и се импрегнира с летливо, физиологично приемливо пенообразуващо средство, при което се получават твърди порести структури.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19635676A DE19635676A1 (de) | 1996-09-03 | 1996-09-03 | Feste geschäumte Wirkstoffzubereitungen |
PCT/EP1997/004550 WO1998009616A1 (de) | 1996-09-03 | 1997-08-21 | Feste geschäumte wirkstoffzubereitungen |
Publications (1)
Publication Number | Publication Date |
---|---|
BG103214A true BG103214A (bg) | 1999-09-30 |
Family
ID=7804471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG103214A BG103214A (bg) | 1996-09-03 | 1999-02-26 | Твърди пянообразуващи препарати, съдържащи активно вещество |
Country Status (22)
Country | Link |
---|---|
US (1) | US6150424A (bg) |
EP (1) | EP0932393B1 (bg) |
JP (1) | JP2000517327A (bg) |
CN (1) | CN1124129C (bg) |
AT (1) | ATE215362T1 (bg) |
AU (1) | AU740856B2 (bg) |
BG (1) | BG103214A (bg) |
BR (1) | BR9711982A (bg) |
CA (1) | CA2264588C (bg) |
CZ (1) | CZ67699A3 (bg) |
DE (2) | DE19635676A1 (bg) |
DK (1) | DK0932393T3 (bg) |
ES (1) | ES2175469T3 (bg) |
HR (1) | HRP970472A2 (bg) |
HU (1) | HUP9904101A3 (bg) |
IL (1) | IL128439A (bg) |
NO (1) | NO991011L (bg) |
PT (1) | PT932393E (bg) |
RU (1) | RU2200004C2 (bg) |
TR (1) | TR199900447T2 (bg) |
WO (1) | WO1998009616A1 (bg) |
ZA (1) | ZA977861B (bg) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19733505A1 (de) * | 1997-08-01 | 1999-02-04 | Knoll Ag | Schnell wirksames Analgeticum |
DE19900457A1 (de) * | 1999-01-08 | 2000-07-13 | Basf Ag | Verfahren zur Herstellung von festen Dosierungsformen |
US6733789B1 (en) | 1999-01-21 | 2004-05-11 | Biovail Laboratories, Inc. | Multiparticulate bisoprolol formulation |
US7364752B1 (en) | 1999-11-12 | 2008-04-29 | Abbott Laboratories | Solid dispersion pharamaceutical formulations |
EP1175205B1 (en) | 1999-11-12 | 2006-06-14 | Abbott Laboratories | Solid dispersion comprising ritonavir, fenofibrate or griseofulvin |
US20040185099A1 (en) * | 2000-01-20 | 2004-09-23 | Biovail Laboratories, Inc. | Multiparticulate bisoprolol formulation |
DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
DE10032456A1 (de) | 2000-07-04 | 2002-01-31 | Lohmann Therapie Syst Lts | Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen |
US6555581B1 (en) | 2001-02-15 | 2003-04-29 | Jones Pharma, Inc. | Levothyroxine compositions and methods |
GB0113841D0 (en) * | 2001-06-07 | 2001-08-01 | Boots Co Plc | Therapeutic agents |
US20030198671A1 (en) * | 2001-08-10 | 2003-10-23 | Franz G. Andrew | Levothyroxine compositions having unique plasma AUC properties |
US20030181524A1 (en) * | 2001-10-29 | 2003-09-25 | Franz G. Andrew | Levothyroxine compositions having unique triiodothyronine Tmax properties |
US20030091633A1 (en) * | 2001-11-15 | 2003-05-15 | John Kelly | Methods and compositions for use of (S)-bisoprolol |
US20030118652A1 (en) * | 2001-11-15 | 2003-06-26 | John Kelly | Methods and compositions for use of (S)-bisoprolol |
WO2003057197A1 (en) * | 2002-01-03 | 2003-07-17 | Smithkline Beecham Corporation | Novel pharmaceutical dosage forms and method for producing same |
DE10207394B4 (de) * | 2002-02-21 | 2007-03-29 | Lts Lohmann Therapie-Systeme Ag | Geschmacksmaskierte oblatenförmige Arzneizubereitung |
US20030235613A1 (en) * | 2002-06-19 | 2003-12-25 | Cts Chemical Industries Ltd. | Popping oral administration form |
DE10227607A1 (de) * | 2002-06-20 | 2004-01-08 | Boxler Gmbh & Co. Kg | Paneel-Verbindung |
PT1592441E (pt) * | 2003-02-06 | 2012-05-21 | Aduro Biotech | Listeria atenuada relativamente à entrada em células não patogénicas, vacinas compreendendo a listeria e métodos para sua utilização |
JP4839209B2 (ja) | 2003-02-06 | 2011-12-21 | アンザ セラピューティクス,インコーポレイテッド | 改変された自由生活微生物、ワクチン組成物、およびそれらの使用方法 |
US7695725B2 (en) | 2003-02-06 | 2010-04-13 | Aduro Biotech | Modified free-living microbes, vaccine compositions and methods of use thereof |
US8802139B2 (en) | 2003-06-26 | 2014-08-12 | Intellipharmaceutics Corp. | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
WO2005023215A2 (en) * | 2003-09-10 | 2005-03-17 | Janssen Pharmaceutica N.V. | Particles shaped as platelets |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
FR2886938B1 (fr) * | 2005-06-10 | 2008-04-18 | Armines Ass Loi De 1901 | Procede d'extrusion permettant de fabriquer des dispersions solides de principes actifs pharmaceutiques dans une matrice polymere |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
JP2012523428A (ja) * | 2009-04-09 | 2012-10-04 | アルカーメス ファーマ アイルランド リミテッド | 放出制御クロザピン組成物 |
CA2786819A1 (en) * | 2010-01-13 | 2011-07-21 | Jazz Pharmaceuticals Plc | Method for titrating clozapine |
EP2552245B1 (en) | 2010-03-26 | 2018-11-14 | Philip Morris Products S.A. | Inhibition of sensory irritation during consumption of non-smokeable tobacco products |
US8952038B2 (en) | 2010-03-26 | 2015-02-10 | Philip Morris Usa Inc. | Inhibition of undesired sensory effects by the compound camphor |
US8636929B2 (en) | 2010-05-21 | 2014-01-28 | Basf Se | Nanoporous foamed active compound-containing preparations based on pharmaceutically acceptable thermoplastically workable polymers |
JP2013526561A (ja) * | 2010-05-21 | 2013-06-24 | ビーエーエスエフ ソシエタス・ヨーロピア | 両親媒性コポリマーを基材とする拡大した表面積を有する生物学的活性物質の製剤 |
EP2571490A2 (en) * | 2010-05-21 | 2013-03-27 | President and Fellows of Harvard College | Foam or particles for applications such as drug delivery |
JP2013527291A (ja) * | 2010-05-21 | 2013-06-27 | ビーエーエスエフ ソシエタス・ヨーロピア | 薬学的に許容可能で熱可塑的に加工可能なポリマーに基づくナノ多孔性の活性成分含有発泡調製物 |
EP2463327A3 (de) * | 2010-12-10 | 2015-06-03 | Basf Se | Verfahren zur herstellung von granulaten, enthaltend mindestens eine wasserlösliche komponente |
US9005635B2 (en) | 2011-03-01 | 2015-04-14 | The Procter & Gamble Company | Articles and processes for making a porous disintegratable solid substrate for personal health care applications |
EP3137113A4 (en) * | 2014-04-30 | 2017-03-22 | Blaesi, Aron H. | Melt-processed polymeric cellular dosage form |
WO2019069108A1 (en) * | 2017-10-04 | 2019-04-11 | Debreceni Egyetem | SOLID GALENIC FORM, MOLDED, GASTRIC RETENTION AND EXTENDED RELEASE AND METHOD OF PREPARING THE SAME |
DE102020110089A1 (de) * | 2020-04-09 | 2021-10-14 | Karl-Franzens-Universität Graz | Verfahren zum Herstellen eines porösen Wirkstoffträgers mittels Heißschmelzextrusion |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3612211A1 (de) * | 1986-04-11 | 1987-10-15 | Basf Ag | Kontinuierliches verfahren zum tablettieren |
DE3612212A1 (de) * | 1986-04-11 | 1987-10-15 | Basf Ag | Verfahren zur herstellung von festen pharmazeutischen formen |
IT1247529B (it) * | 1991-04-24 | 1994-12-17 | Poli Ind Chimica Spa | Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale |
JP2966735B2 (ja) * | 1994-07-29 | 1999-10-25 | 積水化成品工業株式会社 | 熱可塑性樹脂押出機 |
-
1996
- 1996-09-03 DE DE19635676A patent/DE19635676A1/de not_active Withdrawn
-
1997
- 1997-08-21 WO PCT/EP1997/004550 patent/WO1998009616A1/de active IP Right Grant
- 1997-08-21 ES ES97944775T patent/ES2175469T3/es not_active Expired - Lifetime
- 1997-08-21 RU RU99107556/14A patent/RU2200004C2/ru active
- 1997-08-21 TR TR1999/00447T patent/TR199900447T2/xx unknown
- 1997-08-21 PT PT97944775T patent/PT932393E/pt unknown
- 1997-08-21 EP EP97944775A patent/EP0932393B1/de not_active Expired - Lifetime
- 1997-08-21 BR BR9711982A patent/BR9711982A/pt not_active Application Discontinuation
- 1997-08-21 IL IL12843997A patent/IL128439A/xx not_active IP Right Cessation
- 1997-08-21 CZ CZ99676A patent/CZ67699A3/cs unknown
- 1997-08-21 DK DK97944775T patent/DK0932393T3/da active
- 1997-08-21 CN CN97199572A patent/CN1124129C/zh not_active Expired - Lifetime
- 1997-08-21 JP JP10512176A patent/JP2000517327A/ja active Pending
- 1997-08-21 US US09/254,012 patent/US6150424A/en not_active Expired - Lifetime
- 1997-08-21 CA CA002264588A patent/CA2264588C/en not_active Expired - Lifetime
- 1997-08-21 DE DE59706898T patent/DE59706898D1/de not_active Expired - Lifetime
- 1997-08-21 HU HU9904101A patent/HUP9904101A3/hu unknown
- 1997-08-21 AT AT97944775T patent/ATE215362T1/de not_active IP Right Cessation
- 1997-08-21 AU AU46177/97A patent/AU740856B2/en not_active Ceased
- 1997-09-02 ZA ZA977861A patent/ZA977861B/xx unknown
- 1997-09-03 HR HR19635676.8A patent/HRP970472A2/hr not_active Application Discontinuation
-
1999
- 1999-02-26 BG BG103214A patent/BG103214A/bg unknown
- 1999-03-02 NO NO991011A patent/NO991011L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU4617797A (en) | 1998-03-26 |
DE19635676A1 (de) | 1998-03-05 |
EP0932393B1 (de) | 2002-04-03 |
IL128439A (en) | 2003-02-12 |
BR9711982A (pt) | 1999-08-24 |
ATE215362T1 (de) | 2002-04-15 |
NO991011D0 (no) | 1999-03-02 |
TR199900447T2 (xx) | 1999-05-21 |
CA2264588C (en) | 2005-10-18 |
WO1998009616A1 (de) | 1998-03-12 |
ES2175469T3 (es) | 2002-11-16 |
ZA977861B (en) | 1999-03-02 |
CN1237103A (zh) | 1999-12-01 |
RU2200004C2 (ru) | 2003-03-10 |
DK0932393T3 (da) | 2002-07-01 |
JP2000517327A (ja) | 2000-12-26 |
PT932393E (pt) | 2002-09-30 |
HRP970472A2 (en) | 1998-08-31 |
DE59706898D1 (de) | 2002-05-08 |
CZ67699A3 (cs) | 1999-05-12 |
CN1124129C (zh) | 2003-10-15 |
NO991011L (no) | 1999-03-03 |
CA2264588A1 (en) | 1998-03-12 |
HUP9904101A2 (hu) | 2000-04-28 |
HUP9904101A3 (en) | 2001-11-28 |
EP0932393A1 (de) | 1999-08-04 |
AU740856B2 (en) | 2001-11-15 |
IL128439A0 (en) | 2000-01-31 |
US6150424A (en) | 2000-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG103214A (bg) | Твърди пянообразуващи препарати, съдържащи активно вещество | |
ID22349A (id) | Turunan dari 8-azabisiklo [3.2.1] oktana-, 8-azabisiklo [3.2.1] okt-6-ena-, 9-azabisiklo-[3.3.1] nonana-, 9-aza-3-oksabisiklo [3.3.1] nonana- dan 9-aza-3-tiobisiklo [3.3.1] nonana, pembuatannya dan penggunaannya sebagai insektisida | |
EP0600470A3 (en) | Bipolar membrane. | |
EP0681845A3 (en) | Polymer composite implant and process for manufacturing it. | |
EP0688824A3 (de) | Homogene Polmerlegierungen auf der Basis von sulfonierten, aromatischen Polyetherketonen | |
AU7908098A (en) | Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones | |
EP0713893A4 (en) | NORBORNENE-BASED HYDROGEN CYCLE-OPENING POLYMER, PROCESS FOR PRODUCING THE SAME AND USE THEREOF | |
CA2132977A1 (en) | Crosslinked biocompatible encapsulation compositions and methods | |
MX210213B (es) | Procedimiento de obtencion de polimeros hidrosolubles, polimeros obtenidos y sus usos. | |
AU3513095A (en) | Carbon containing vascular graft and method for making same | |
AU2576495A (en) | Fluoroolefin, fluoropolymer, and thermoplastic resin composition containing the polymer | |
AU5461598A (en) | Mesoporous-silica films, fibers, and powders by evaporation | |
DE59008217D1 (de) | Hydrophile quellfähige Pfropfpolymerisate, deren Herstellung und Verwendung. | |
EP0402901A3 (en) | Polytetrafluoroethylene porous material and process for producing the same | |
WO1991001621A3 (en) | Composites and methods for making same | |
AU3619295A (en) | Antiinflammatory agent for external use | |
DE68916357D1 (de) | Kern-Schale-Polymer, Zusammensetzung und Formteile davon. | |
ZA985471B (en) | Absorbent structure comprising a highly absorbent polymer and an absorbent article comprising the absorbent structure | |
EP0853883A4 (en) | CHEMICAL COMPOSITION FOR AGRICULTURAL USE WITH IMPROVED RAIN DROP RESISTANCE | |
MX9603645A (es) | Materiales antimicrobianos. | |
EP1002793A4 (en) | PHYSIOLOGICALLY ACTIVE SUBSTANCES TKR2449, METHOD FOR THEIR PRODUCTION AND MICROORGANISMS | |
AU2464097A (en) | 1,4-diaryl-2-fluoro-2-butene insecticidal and acaricidal agents | |
AU2316897A (en) | Cyclic imido-1,3,5-triazine crosslinking agents | |
EP0666280A3 (en) | Polymethyl-3,3,3-trifluoropropylsiloxanes stereoregular and process for their preparation. | |
UA48245C2 (uk) | ЗАМІЩЕНІ 1,2,3,4-ТЕТРАГІДРО-2-ДИБЕНЗОФУРАНАМІНИ ТА 2-АМІНОЦИКЛОГЕПТА[B]БЕНЗОФУРАНИ, ФАРМАЦЕВТИЧНА ЛІКАРСЬКА ФОРМА ТА СПОСІБ ПІДВИЩЕННЯ АКТИВАЦІЇ 5-НТ<sub>1F</sub> РЕЦЕПТОРА У ССАВЦЯ |